Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts
Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts ...
STAT10h
Pharmalittle: We’re reading about FDA OK for Vertex non-opioid pain drug, vaccine advisory committee, and more
Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product that has simultaneously sparked high hopes and ...
RFK Jr. fields pharma questions on Day Two
After two days of making his case to Senate committees, Robert F. Kennedy Jr.’s bid to lead federal health agencies still ...
nptelegraph8h
Next week's Unicam hearings include Medicaid, youth social media use
Unicameral committees start taking testimony at 1:30 p.m. on bills scheduled that day. Livestreams of hearings and texts of ...
Illinois lawmakers revive push to create prescription drug affordability board
Legislators and medical policy advocates revealed the proposal at a press conference Wednesday at the capitol in Springfield. The measure, House Bill 1443 is backed by Sen. Robert Peters, D-Chicago, ...
FDA Approves First Non-Opioid Pain Pill, As Medical Marijuana Remains A Proven Alternative For Relief
FDA approves non-opioid pain reliever, suzetrigine, by Vertex Pharmaceuticals to mitigate risks of opioids and provide ...
Map Shows States With Medicaid Work Requirements
Introducing work requirements for Medicaid recipients is something the GOP has suggested will be brought into action.
ENDPOINTS NEWS5h
Genen­tech joins suits against STD clin­ics it says get 'un­law­ful' 340B dis­counts
Genentech sues federal government over 340B discounts to STD clinics, joining Amgen, Eli Lilly and UCB in challenging program eligibility.
Modern Healthcare6h
Where Medicaid covers the most children, adults by state
Providers have expressed concerns that potential cuts to the program could lead to an increase in uncompensated care.